Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Finasteride helps female-pattern hair loss.

Certain Dibenzo derivatives may help treat prostate cancer.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

SHH protein helps nerve regeneration in hypertensive rats.

ROR2 is crucial for hair follicle stem cell maintenance and self-renewal.

AH-001 could be a safer and more effective treatment for hair loss.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Retinol and L-cystine improve diffuse hair loss without side effects.

Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Early diagnosis and treatment of congenital adrenal hyperplasia are crucial to manage symptoms and prevent complications.